img

Global CD20 Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CD20 Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

CD20 Antibody is an unconjugated antibody to CD20.
CD20 Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CD20 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for CD20 Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, CD20 Antibody key manufacturers include Sino Biological, Inc., Thermo Fisher, Creative Diagnostics, Cepham Life Sciences, Creative Biolabs, LifeSpan BioSciences, Inc, Abbexa, Biorbyt and Abcam, etc. Sino Biological, Inc., Thermo Fisher, Creative Diagnostics are top 3 players and held % sales share in total in 2022.
CD20 Antibody can be divided into Monoclonal Antibody and Polyclonal Antibody, etc. Monoclonal Antibody is the mainstream product in the market, accounting for % sales share globally in 2022.
CD20 Antibody is widely used in various fields, such as Flow Cytometry, ELISA, Western Blot and Immunoprecipitation, etc. Flow Cytometry provides greatest supports to the CD20 Antibody industry development. In 2022, global % sales of CD20 Antibody went into Flow Cytometry filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CD20 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sino Biological, Inc.
Thermo Fisher
Creative Diagnostics
Cepham Life Sciences
Creative Biolabs
LifeSpan BioSciences, Inc
Abbexa
Biorbyt
Abcam
Bio-Techne
MyBiosource, Inc.
Boster Biological Technology
Segment by Type
Monoclonal Antibody
Polyclonal Antibody

Segment by Application


Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CD20 Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of CD20 Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the CD20 Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of CD20 Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, CD20 Antibody introduction, etc. CD20 Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of CD20 Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 CD20 Antibody Market Overview
1.1 CD20 Antibody Product Overview
1.2 CD20 Antibody Market Segment by Type
1.2.1 Monoclonal Antibody
1.2.2 Polyclonal Antibody
1.3 Global CD20 Antibody Market Size by Type
1.3.1 Global CD20 Antibody Market Size Overview by Type (2018-2029)
1.3.2 Global CD20 Antibody Historic Market Size Review by Type (2018-2024)
1.3.3 Global CD20 Antibody Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America CD20 Antibody Sales Breakdown by Type (2018-2024)
1.4.2 Europe CD20 Antibody Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific CD20 Antibody Sales Breakdown by Type (2018-2024)
1.4.4 Latin America CD20 Antibody Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa CD20 Antibody Sales Breakdown by Type (2018-2024)
2 Global CD20 Antibody Market Competition by Company
2.1 Global Top Players by CD20 Antibody Sales (2018-2024)
2.2 Global Top Players by CD20 Antibody Revenue (2018-2024)
2.3 Global Top Players by CD20 Antibody Price (2018-2024)
2.4 Global Top Manufacturers CD20 Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 CD20 Antibody Market Competitive Situation and Trends
2.5.1 CD20 Antibody Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by CD20 Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CD20 Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into CD20 Antibody Market
2.8 Key Manufacturers CD20 Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 CD20 Antibody Status and Outlook by Region
3.1 Global CD20 Antibody Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global CD20 Antibody Historic Market Size by Region
3.2.1 Global CD20 Antibody Sales in Volume by Region (2018-2024)
3.2.2 Global CD20 Antibody Sales in Value by Region (2018-2024)
3.2.3 Global CD20 Antibody Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global CD20 Antibody Forecasted Market Size by Region
3.3.1 Global CD20 Antibody Sales in Volume by Region (2024-2029)
3.3.2 Global CD20 Antibody Sales in Value by Region (2024-2029)
3.3.3 Global CD20 Antibody Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global CD20 Antibody by Application
4.1 CD20 Antibody Market Segment by Application
4.1.1 Flow Cytometry
4.1.2 ELISA
4.1.3 Western Blot
4.1.4 Immunoprecipitation
4.1.5 Immunofluorescence
4.1.6 Others
4.2 Global CD20 Antibody Market Size by Application
4.2.1 Global CD20 Antibody Market Size Overview by Application (2018-2029)
4.2.2 Global CD20 Antibody Historic Market Size Review by Application (2018-2024)
4.2.3 Global CD20 Antibody Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America CD20 Antibody Sales Breakdown by Application (2018-2024)
4.3.2 Europe CD20 Antibody Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific CD20 Antibody Sales Breakdown by Application (2018-2024)
4.3.4 Latin America CD20 Antibody Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa CD20 Antibody Sales Breakdown by Application (2018-2024)
5 North America CD20 Antibody by Country
5.1 North America CD20 Antibody Historic Market Size by Country
5.1.1 North America CD20 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America CD20 Antibody Sales in Volume by Country (2018-2024)
5.1.3 North America CD20 Antibody Sales in Value by Country (2018-2024)
5.2 North America CD20 Antibody Forecasted Market Size by Country
5.2.1 North America CD20 Antibody Sales in Volume by Country (2024-2029)
5.2.2 North America CD20 Antibody Sales in Value by Country (2024-2029)
6 Europe CD20 Antibody by Country
6.1 Europe CD20 Antibody Historic Market Size by Country
6.1.1 Europe CD20 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe CD20 Antibody Sales in Volume by Country (2018-2024)
6.1.3 Europe CD20 Antibody Sales in Value by Country (2018-2024)
6.2 Europe CD20 Antibody Forecasted Market Size by Country
6.2.1 Europe CD20 Antibody Sales in Volume by Country (2024-2029)
6.2.2 Europe CD20 Antibody Sales in Value by Country (2024-2029)
7 Asia-Pacific CD20 Antibody by Region
7.1 Asia-Pacific CD20 Antibody Historic Market Size by Region
7.1.1 Asia-Pacific CD20 Antibody Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific CD20 Antibody Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific CD20 Antibody Sales in Value by Region (2018-2024)
7.2 Asia-Pacific CD20 Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific CD20 Antibody Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific CD20 Antibody Sales in Value by Region (2024-2029)
8 Latin America CD20 Antibody by Country
8.1 Latin America CD20 Antibody Historic Market Size by Country
8.1.1 Latin America CD20 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America CD20 Antibody Sales in Volume by Country (2018-2024)
8.1.3 Latin America CD20 Antibody Sales in Value by Country (2018-2024)
8.2 Latin America CD20 Antibody Forecasted Market Size by Country
8.2.1 Latin America CD20 Antibody Sales in Volume by Country (2024-2029)
8.2.2 Latin America CD20 Antibody Sales in Value by Country (2024-2029)
9 Middle East and Africa CD20 Antibody by Country
9.1 Middle East and Africa CD20 Antibody Historic Market Size by Country
9.1.1 Middle East and Africa CD20 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa CD20 Antibody Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa CD20 Antibody Sales in Value by Country (2018-2024)
9.2 Middle East and Africa CD20 Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa CD20 Antibody Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa CD20 Antibody Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sino Biological, Inc.
10.1.1 Sino Biological, Inc. Company Information
10.1.2 Sino Biological, Inc. Introduction and Business Overview
10.1.3 Sino Biological, Inc. CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sino Biological, Inc. CD20 Antibody Products Offered
10.1.5 Sino Biological, Inc. Recent Development
10.2 Thermo Fisher
10.2.1 Thermo Fisher Company Information
10.2.2 Thermo Fisher Introduction and Business Overview
10.2.3 Thermo Fisher CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Thermo Fisher CD20 Antibody Products Offered
10.2.5 Thermo Fisher Recent Development
10.3 Creative Diagnostics
10.3.1 Creative Diagnostics Company Information
10.3.2 Creative Diagnostics Introduction and Business Overview
10.3.3 Creative Diagnostics CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Creative Diagnostics CD20 Antibody Products Offered
10.3.5 Creative Diagnostics Recent Development
10.4 Cepham Life Sciences
10.4.1 Cepham Life Sciences Company Information
10.4.2 Cepham Life Sciences Introduction and Business Overview
10.4.3 Cepham Life Sciences CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Cepham Life Sciences CD20 Antibody Products Offered
10.4.5 Cepham Life Sciences Recent Development
10.5 Creative Biolabs
10.5.1 Creative Biolabs Company Information
10.5.2 Creative Biolabs Introduction and Business Overview
10.5.3 Creative Biolabs CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Creative Biolabs CD20 Antibody Products Offered
10.5.5 Creative Biolabs Recent Development
10.6 LifeSpan BioSciences, Inc
10.6.1 LifeSpan BioSciences, Inc Company Information
10.6.2 LifeSpan BioSciences, Inc Introduction and Business Overview
10.6.3 LifeSpan BioSciences, Inc CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.6.4 LifeSpan BioSciences, Inc CD20 Antibody Products Offered
10.6.5 LifeSpan BioSciences, Inc Recent Development
10.7 Abbexa
10.7.1 Abbexa Company Information
10.7.2 Abbexa Introduction and Business Overview
10.7.3 Abbexa CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Abbexa CD20 Antibody Products Offered
10.7.5 Abbexa Recent Development
10.8 Biorbyt
10.8.1 Biorbyt Company Information
10.8.2 Biorbyt Introduction and Business Overview
10.8.3 Biorbyt CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Biorbyt CD20 Antibody Products Offered
10.8.5 Biorbyt Recent Development
10.9 Abcam
10.9.1 Abcam Company Information
10.9.2 Abcam Introduction and Business Overview
10.9.3 Abcam CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Abcam CD20 Antibody Products Offered
10.9.5 Abcam Recent Development
10.10 Bio-Techne
10.10.1 Bio-Techne Company Information
10.10.2 Bio-Techne Introduction and Business Overview
10.10.3 Bio-Techne CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bio-Techne CD20 Antibody Products Offered
10.10.5 Bio-Techne Recent Development
10.11 MyBiosource, Inc.
10.11.1 MyBiosource, Inc. Company Information
10.11.2 MyBiosource, Inc. Introduction and Business Overview
10.11.3 MyBiosource, Inc. CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.11.4 MyBiosource, Inc. CD20 Antibody Products Offered
10.11.5 MyBiosource, Inc. Recent Development
10.12 Boster Biological Technology
10.12.1 Boster Biological Technology Company Information
10.12.2 Boster Biological Technology Introduction and Business Overview
10.12.3 Boster Biological Technology CD20 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Boster Biological Technology CD20 Antibody Products Offered
10.12.5 Boster Biological Technology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 CD20 Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 CD20 Antibody Industrial Chain Analysis
11.4 CD20 Antibody Market Dynamics
11.4.1 CD20 Antibody Industry Trends
11.4.2 CD20 Antibody Market Drivers
11.4.3 CD20 Antibody Market Challenges
11.4.4 CD20 Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 CD20 Antibody Distributors
12.3 CD20 Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal Antibody
Table 2. Major Company of Polyclonal Antibody
Table 3. Global CD20 Antibody Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global CD20 Antibody Sales by Type (2018-2024) & (K Units)
Table 5. Global CD20 Antibody Sales Market Share in Volume by Type (2018-2024)
Table 6. Global CD20 Antibody Sales by Type (2018-2024) & (US& Million)
Table 7. Global CD20 Antibody Market Share in Value by Type (2018-2024)
Table 8. Global CD20 Antibody Price by Type (2018-2024) & (US$/Unit)
Table 9. Global CD20 Antibody Sales by Type (2024-2029) & (K Units)
Table 10. Global CD20 Antibody Sales Market Share in Volume by Type (2024-2029)
Table 11. Global CD20 Antibody Sales by Type (2024-2029) & (US$ Million)
Table 12. Global CD20 Antibody Sales Market Share in Value by Type (2024-2029)
Table 13. Global CD20 Antibody Price by Type (2024-2029) & (US$/Unit)
Table 14. North America CD20 Antibody Sales by Type (2018-2024) & (K Units)
Table 15. North America CD20 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe CD20 Antibody Sales (K Units) by Type (2018-2024)
Table 17. Europe CD20 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific CD20 Antibody Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific CD20 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America CD20 Antibody Sales (K Units) by Type (2018-2024)
Table 21. Latin America CD20 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa CD20 Antibody Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa CD20 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 24. Global CD20 Antibody Sales by Company (2018-2024) & (K Units)
Table 25. Global CD20 Antibody Sales Share by Company (2018-2024)
Table 26. Global CD20 Antibody Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global CD20 Antibody Revenue Share by Company (2018-2024)
Table 28. Global Market CD20 Antibody Price by Company (2018-2024) & (US$/Unit)
Table 29. Global CD20 Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global CD20 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CD20 Antibody as of 2022)
Table 32. Date of Key Manufacturers Enter into CD20 Antibody Market
Table 33. Key Manufacturers CD20 Antibody Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global CD20 Antibody Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global CD20 Antibody Sales by Region (2018-2024) & (K Units)
Table 37. Global CD20 Antibody Sales Market Share in Volume by Region (2018-2024)
Table 38. Global CD20 Antibody Sales by Region (2018-2024) & (US$ Million)
Table 39. Global CD20 Antibody Sales Market Share in Value by Region (2018-2024)
Table 40. Global CD20 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global CD20 Antibody Sales by Region (2024-2029) & (K Units)
Table 42. Global CD20 Antibody Sales Market Share in Volume by Region (2024-2029)
Table 43. Global CD20 Antibody Sales by Region (2024-2029) & (US$ Million)
Table 44. Global CD20 Antibody Sales Market Share in Value by Region (2024-2029)
Table 45. Global CD20 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global CD20 Antibody Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global CD20 Antibody Sales by Application (2018-2024) & (K Units)
Table 48. Global CD20 Antibody Sales Market Share in Volume by Application (2018-2024)
Table 49. Global CD20 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 50. Global CD20 Antibody Sales Market Share in Value by Application (2018-2024)
Table 51. Global CD20 Antibody Price by Application (2018-2024) & (US$/Unit)
Table 52. Global CD20 Antibody Sales by Application (2024-2029) & (K Units)
Table 53. Global CD20 Antibody Sales Market Share in Volume by Application (2024-2029)
Table 54. Global CD20 Antibody Sales by Application (2024-2029) & (US$ Million)
Table 55. Global CD20 Antibody Sales Market Share in Value by Application (2024-2029)
Table 56. Global CD20 Antibody Price by Application (2024-2029) & (US$/Unit)
Table 57. North America CD20 Antibody Sales by Application (2018-2024) (K Units)
Table 58. North America CD20 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe CD20 Antibody Sales by Application (2018-2024) (K Units)
Table 60. Europe CD20 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific CD20 Antibody Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific CD20 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America CD20 Antibody Sales by Application (2018-2024) (K Units)
Table 64. Latin America CD20 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa CD20 Antibody Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa CD20 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 67. North America CD20 Antibody Sales by Country (2018-2024) & (K Units)
Table 68. North America CD20 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 69. North America CD20 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 70. North America CD20 Antibody Sales Market Share in Value by Country (2018-2024)
Table 71. North America CD20 Antibody Sales by Country (2024-2029) & (K Units)
Table 72. North America CD20 Antibody Sales Market Share in Volume by Country (2024-2029)
Table 73. North America CD20 Antibody Sales by Country (2024-2029) & (US$ Million)
Table 74. North America CD20 Antibody Sales Market Share in Value by Country (2024-2029)
Table 75. Europe CD20 Antibody Sales by Country (2018-2024) & (K Units)
Table 76. Europe CD20 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe CD20 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe CD20 Antibody Sales Market Share in Value by Country (2018-2024)
Table 79. Europe CD20 Antibody Sales by Country (2024-2029) & (K Units)
Table 80. Europe CD20 Antibody Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe CD20 Antibody Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe CD20 Antibody Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific CD20 Antibody Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific CD20 Antibody Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific CD20 Antibody Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific CD20 Antibody Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific CD20 Antibody Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific CD20 Antibody Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific CD20 Antibody Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific CD20 Antibody Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America CD20 Antibody Sales by Country (2018-2024) & (K Units)
Table 92. Latin America CD20 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America CD20 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America CD20 Antibody Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America CD20 Antibody Sales by Country (2024-2029) & (K Units)
Table 96. Latin America CD20 Antibody Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America CD20 Antibody Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America CD20 Antibody Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa CD20 Antibody Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa CD20 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa CD20 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa CD20 Antibody Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa CD20 Antibody Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa CD20 Antibody Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa CD20 Antibody Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa CD20 Antibody Sales Market Share in Value by Country (2024-2029)
Table 107. Sino Biological, Inc. Company Information
Table 108. Sino Biological, Inc. Introduction and Business Overview
Table 109. Sino Biological, Inc. CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sino Biological, Inc. CD20 Antibody Product
Table 111. Sino Biological, Inc. Recent Development
Table 112. Thermo Fisher Company Information
Table 113. Thermo Fisher Introduction and Business Overview
Table 114. Thermo Fisher CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Thermo Fisher CD20 Antibody Product
Table 116. Thermo Fisher Recent Development
Table 117. Creative Diagnostics Company Information
Table 118. Creative Diagnostics Introduction and Business Overview
Table 119. Creative Diagnostics CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Creative Diagnostics CD20 Antibody Product
Table 121. Creative Diagnostics Recent Development
Table 122. Cepham Life Sciences Company Information
Table 123. Cepham Life Sciences Introduction and Business Overview
Table 124. Cepham Life Sciences CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Cepham Life Sciences CD20 Antibody Product
Table 126. Cepham Life Sciences Recent Development
Table 127. Creative Biolabs Company Information
Table 128. Creative Biolabs Introduction and Business Overview
Table 129. Creative Biolabs CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Creative Biolabs CD20 Antibody Product
Table 131. Creative Biolabs Recent Development
Table 132. LifeSpan BioSciences, Inc Company Information
Table 133. LifeSpan BioSciences, Inc Introduction and Business Overview
Table 134. LifeSpan BioSciences, Inc CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. LifeSpan BioSciences, Inc CD20 Antibody Product
Table 136. LifeSpan BioSciences, Inc Recent Development
Table 137. Abbexa Company Information
Table 138. Abbexa Introduction and Business Overview
Table 139. Abbexa CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Abbexa CD20 Antibody Product
Table 141. Abbexa Recent Development
Table 142. Biorbyt Company Information
Table 143. Biorbyt Introduction and Business Overview
Table 144. Biorbyt CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Biorbyt CD20 Antibody Product
Table 146. Biorbyt Recent Development
Table 147. Abcam Company Information
Table 148. Abcam Introduction and Business Overview
Table 149. Abcam CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Abcam CD20 Antibody Product
Table 151. Abcam Recent Development
Table 152. Bio-Techne Company Information
Table 153. Bio-Techne Introduction and Business Overview
Table 154. Bio-Techne CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Bio-Techne CD20 Antibody Product
Table 156. Bio-Techne Recent Development
Table 157. MyBiosource, Inc. Company Information
Table 158. MyBiosource, Inc. Introduction and Business Overview
Table 159. MyBiosource, Inc. CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. MyBiosource, Inc. CD20 Antibody Product
Table 161. MyBiosource, Inc. Recent Development
Table 162. Boster Biological Technology Company Information
Table 163. Boster Biological Technology Introduction and Business Overview
Table 164. Boster Biological Technology CD20 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Boster Biological Technology CD20 Antibody Product
Table 166. Boster Biological Technology Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. CD20 Antibody Market Trends
Table 170. CD20 Antibody Market Drivers
Table 171. CD20 Antibody Market Challenges
Table 172. CD20 Antibody Market Restraints
Table 173. CD20 Antibody Distributors List
Table 174. CD20 Antibody Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. CD20 Antibody Product Picture
Figure 2. Global CD20 Antibody Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global CD20 Antibody Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global CD20 Antibody Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Monoclonal Antibody
Figure 6. Global Monoclonal Antibody Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Polyclonal Antibody
Figure 8. Global Polyclonal Antibody Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global CD20 Antibody Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global CD20 Antibody Sales Market Share by Type in 2022 & 2029
Figure 11. North America CD20 Antibody Sales Market Share in Volume by Type in 2022
Figure 12. North America CD20 Antibody Sales Market Share in Value by Type in 2022
Figure 13. Europe CD20 Antibody Sales Market Share in Volume by Type in 2022
Figure 14. Europe CD20 Antibody Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific CD20 Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific CD20 Antibody Sales Market Share in Value by Type in 2022
Figure 17. Latin America CD20 Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Latin America CD20 Antibody Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa CD20 Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa CD20 Antibody Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by CD20 Antibody Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by CD20 Antibody Revenue in 2022
Figure 23. CD20 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Flow Cytometry
Figure 25. Global Flow Cytometry Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of ELISA
Figure 27. Global ELISA Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Western Blot
Figure 29. Global Western Blot Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Immunoprecipitation
Figure 31. Global Immunoprecipitation Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Immunofluorescence
Figure 33. Global Immunofluorescence Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global CD20 Antibody Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global CD20 Antibody Sales Market Share by Application in 2022 & 2029
Figure 38. North America CD20 Antibody Sales Market Share in Volume by Application in 2022
Figure 39. North America CD20 Antibody Sales Market Share in Value by Application in 2022
Figure 40. Europe CD20 Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Europe CD20 Antibody Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific CD20 Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific CD20 Antibody Sales Market Share in Value by Application in 2022
Figure 44. Latin America CD20 Antibody Sales Market Share in Volume by Application in 2022
Figure 45. Latin America CD20 Antibody Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa CD20 Antibody Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. CD20 Antibody Manufacturing Cost Structure
Figure 49. CD20 Antibody Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed